Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-11-22

Clinical Trial Update: Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain

View source ↗

Summary

A completed clinical trial in Spain characterising and epidemiologically describing breakthrough cancer pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Takeda | Conditions: Breakthrough Cancer Pain | Status: COMPLETED | Results posted: 2019-11-22